About: Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $16.28 (-3.70%)
FRNMNASDAQFreenome, Inc. Common stock
Loading watchlist status…
Freenome, Inc. Common stock share price
FRNM price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
FRNM price performance
10.04%
5D
49.18%
1M
45.31%
YTD
45.31%
1Y
FRNM price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/AFRNM details
FRNM Market Signals